AXUNIL NASAL SPRAY 9 GM

AXUNIL NASAL SPRAY 9 GM works by reducing inflammation in the airways and nasal passages, thereby relieving symptoms such as congestion, sneezing, and difficulty breathing.

AXUNIL NASAL SPRAY 9 GM exerts its therapeutic effects by acting as a potent anti-inflammatory agent. When administered as an inhaler or nasal spray, it targets the airways or nasal passages, respectively. The medication binds to glucocorticoid receptors within cells, triggering a cascade of biochemical reactions that result in the inhibition of inflammatory processes. AXUNIL NASAL SPRAY 9 GM suppresses the production of pro-inflammatory cytokines, reduces the recruitment of inflammatory cells, and inhibits the release of chemical mediators involved in allergic responses. These actions help decrease swelling, mucus production, and airway hyperresponsiveness. By reducing airway inflammation, AXUNIL NASAL SPRAY 9 GM improves breathing, alleviates symptoms like coughing, wheezing, and shortness of breath, and helps prevent asthma exacerbations. In allergic rhinitis, it attenuates nasal congestion, sneezing, itching, and rhinorrhea. AXUNIL NASAL SPRAY 9 GM local action minimizes systemic exposure, thereby reducing the risk of systemic side effects associated with corticosteroid use.